Eledon Pharmaceuticals
Irvine
About Eledon Pharmaceuticals
Eledon Pharmaceuticals is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation and for people with autoimmune and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $417.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:NVUS
- Website: eledon.com
- Phone: +1 949-238-8090
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eledon-pharmaceuticals-7433 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.